Stock 9939 KINTOR PHARMACEUTICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Kintor Pharmaceutical Limited

Equities

9939

KYG5273B1077

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:13 2024-04-23 am EDT 		5-day change 1st Jan Change
0.96 HKD -5.88% Intraday chart for Kintor Pharmaceutical Limited +9.09% -41.10%
Apr. 22 Kintor Pharmaceutical Limited Announces Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China Reaches Primary Endpoint CI
Apr. 22 Kintor Pharmaceutical Concludes Phase II Clinical Trial for Androgenic Alopecia Treatment MT

Business Summary

Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China. The Company is focused on the research and development of drugs for cancers and other androgen receptor (AR) related diseases. Its primary drug candidate is Proxalutamide which is in phase III clinical trials in China for metastatic castration-resistant prostate cancer (mCRPC). The Company are also developing other drug candidates, including a phase II small molecule drug candidate Pyrilutamide, a phase II monoclonal antibody drug candidate ALK-1, a phase I mTOR inhibitor drug candidate Detorsertib and an inhibitor of the hedgehog signal translation pathway GT1708F.

Number of employees: 225

Managers

Managers TitleAgeSince
You Zhi Tong CEO
 Chief Executive Officer - 09-03-23
Ming Ming Cheung DFI
 Director of Finance/CFO 47 21-08-31
Zhi Hua Ren CTO
 Chief Tech/Sci/R&D Officer - 20-09-30
Xiang Ni CTO
 Chief Tech/Sci/R&D Officer 55 23-02-28
Qun Lu CTO
 Chief Tech/Sci/R&D Officer 58 21-05-09
Liandong Ma CTO
 Chief Tech/Sci/R&D Officer - -
Wai Chiu Wong IRC
 Investor Relations Contact 69 22-02-16
Jiawen Han PRN
 Corporate Officer/Principal - 21-05-14
Guohao Zhou PRN
 Corporate Officer/Principal 64 17-07-31
Mingming Yan SAM
 Sales & Marketing 45 19-06-16

Members of the board

Members of the board TitleAgeSince
Wei Peng Gao BRD
 Director/Board Member 49 21-06-21
Cheng Wei Liu BRD
 Director/Board Member 54 22-05-04
You Zhi Tong CEO
 Chief Executive Officer - 09-03-23
Min Xu BRD
 Director/Board Member 59 19-08-11
Yeung Wai Yim BRD
 Director/Board Member 60 19-08-11
Liang Tong BRD
 Director/Board Member 60 20-10-26
Qun Lu CTO
 Chief Tech/Sci/R&D Officer 58 21-05-09
Ge Qi Wei BRD
 Director/Board Member 50 21-09-26
Xiang Ni CTO
 Chief Tech/Sci/R&D Officer 55 23-02-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 447,499,600 359,636,431 ( 80.37 %) 0 80.37 %

Shareholders

NameEquities%Valuation
You Zhi Tong
9.163 %
41,004,770 9.163 % 5 M $
Zhuhai State-Owned Assets Supervision & Admin. Commission
5.489 %
24,564,017 5.489 % 3 M $
Chuang Xin Guo
4.913 %
21,984,899 4.913 % 2 M $
Kiya Co. Ltd.
4.568 %
20,439,808 4.568 % 2 M $
LEGEND HOLDINGS CORPORATION
4.553 %
20,374,500 4.553 % 2 M $
Caitong Fund Management Co., Ltd.
0.6785 %
3,036,500 0.6785 % 333 651 $
Penghua Fund Management Co., Ltd.
0.2561 %
1,146,000 0.2561 % 125 922 $
Zhong Ou Asset Management Co., Ltd
0.0483 %
216,000 0.0483 % 23 734 $
Bosera Asset Management Co., Ltd.
0.0291 %
130,000 0.0291 % 14 284 $
Hwabao WP Fund Management Co., Ltd.
0.0109 %
49,000 0.0109 % 5 384 $

Company contact information

Kintor Pharmaceutical Ltd.

Suzhou Industrial Park No. 20 Songbei Road

215123, Suzhou

+

http://www.kintor.com.cn
address Kintor Pharmaceutical Limited(9939)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8876 CNY
Average target price
13.21 CNY
Spread / Average Target
+1,388.33%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
KINTOR PHARMACEUTICAL LIMITED Stock Kintor Pharmaceutical Limited
-41.10% 58.25M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-0.56% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+3.33% 96.73B
ARGENX SE Stock argenx SE
+1.66% 21.31B
BIONTECH SE Stock BioNTech SE
-16.48% 21.21B
GENMAB A/S Stock Genmab A/S
-6.82% 18.79B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.41% 16.37B
BEIGENE, LTD. Stock BeiGene, Ltd.
-23.78% 13.68B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.97% 13.44B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+22.42% 10.98B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 9939 Stock
  4. Company Kintor Pharmaceutical Limited